Intervention Review

Azathioprine as an oral corticosteroid sparing agent for asthma

  1. Taraneh P Dean1,*,
  2. Ann Dewey1,
  3. Anna Bara2,
  4. Toby J Lasserson3,
  5. E. Haydn Walters4

Editorial Group: Cochrane Airways Group

Published Online: 20 OCT 2003

Assessed as up-to-date: 5 AUG 2010

DOI: 10.1002/14651858.CD003270.pub2

How to Cite

Dean TP, Dewey A, Bara A, Lasserson TJ, Walters EH. Azathioprine as an oral corticosteroid sparing agent for asthma. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003270. DOI: 10.1002/14651858.CD003270.pub2.

Author Information

  1. 1

    University of Portsmouth, School of Health Sciences & Social Work, Portsmouth, Hampshire, UK

  2. 2

    Clinical Trials Unit, Medical Research Unit, London, UK

  3. 3

    The Cochrane Collaboration, Cochrane Editorial Unit, London, UK

  4. 4

    University of Tasmania, Menzies Research Institute, Hobart, Tasmania, Australia

*Taraneh P Dean, School of Health Sciences & Social Work, University of Portsmouth, James Watson (West), 2 King Richard 1st Road, Portsmouth, Hampshire, PO1 2FR, UK.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 OCT 2003


Cited in:


This article has been cited by:

  1. 1
    Behzad Yeganeh, Subhendu Mukherjee, Lyn M. Moir, Kuldeep Kumawat, Hessam H. Kashani, Rushita A. Bagchi, Hoeke A. Baarsma, Reinoud Gosens, Saeid Ghavami, Novel non-canonical TGF-β signaling networks: Emerging roles in airway smooth muscle phenotype and function, Pulmonary Pharmacology & Therapeutics, 2013, 26, 1, 50


  2. 2
    Paul D. Robinson, Peter Van Asperen, Asthma in Childhood, Pediatric Clinics of North America, 2009, 56, 1, 191


  3. 3
    Stephen P. Peters, Gary Ferguson, Yamo Deniz, Colin Reisner, Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment, Respiratory Medicine, 2006, 100, 7, 1139